Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.
about
Opportunities to address lung cancer disparities among African AmericansPatient preference and contraindications in measuring quality of care: what do administrative data miss?Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.Monitoring and evaluating the quality of cancer care in Japan using administrative claims data.Cultural factors associated with racial disparities in lung cancer care.Impact of Health Insurance Expansion on the Treatment of Colorectal Cancer.Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system.Direct costs of radiotherapy for rectal cancer: a microcosting studyGuideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States.Evidence-practice gaps in lung cancer: A scoping review.Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer.Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.Disparities in Lung Cancer Care and Outcomes among Elderly in a Medically Underserved State Population-A Cancer Registry-Linked Database Study.Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients' treatment decisions.Examining potential colorectal cancer care disparities in the Veterans Affairs health care system.An examination of racial differences in process and outcome of colorectal cancer care quality among users of the veterans affairs health care systemAttitudes and beliefs toward lung cancer screening among US Veterans.Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival.Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer.Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival.The medicalization of obesity, bariatric surgery, and population health.Adherence to cancer treatment guidelines: influence of general and cancer-specific guideline characteristics.Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.Elderly patients with colon cancer have unique tumor characteristics and poor survival.Inpatient bariatric surgery among eligible black and white men and women in the United States, 1999-2010.Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.Interaction between age and race alters predicted survival in colorectal cancer.
P2860
Q26829397-0C57156C-8D4B-4293-8FD2-8093F83925DAQ30644505-A0D26BE2-B597-4B30-97E5-E1A3337DA8D4Q30836526-7AE59EC1-4174-4F17-BFFD-75C1C64E2677Q31010119-1A9F1966-C26D-4C9E-9A3F-76DE18063EA8Q33792856-898B0053-6BC9-4863-BC1C-47EBF54C9871Q33816564-D1D77C6C-A9FD-4B62-B169-C39E5910A13CQ34982425-52E37005-0527-4605-A5AF-D88684C9FB04Q35620648-565B6D34-BD91-45B6-8356-AB2B498132EDQ35668438-9CA36DCC-CBB7-4602-912A-06F2D9E69169Q36162124-DEB5B1A7-134F-4115-A1A4-0B15BB2FB005Q37044288-6C0CA055-8433-402C-B86E-BA5AF06F6DF3Q37053315-8235C1C8-CD86-46FC-BEF1-5628D429BBCAQ37065671-C5C67E3C-A940-4509-9125-080D0AAB4329Q37081326-F8F0798A-6BBD-473C-8E57-8531E5EBC245Q37128095-714E7632-C091-4844-92BB-4C587CEAD700Q37195246-4DC9A380-A790-4375-80E0-39A67FFF3085Q37338144-D33BF098-249F-4A62-9C47-CF275E803908Q37359220-480A40AD-4985-4A41-AB03-EC51CE89B7BFQ37558947-EC467951-9CB6-4BE2-B0A0-FAAF475CE2FAQ38004841-1A20748E-D006-4DCF-B994-49DB82D89D1FQ38767113-6E66254A-686A-4C03-8A4C-34583796C9FAQ38816190-12DD0518-0B52-4ECE-8D8A-D01D56A732F3Q38830746-329236C9-1D4D-4480-A085-DDCAA0145C0FQ39066307-31DFED04-4A4D-478B-82D8-A184FB04B58BQ40605730-9F71F59B-A4BF-4BE5-BA84-390DCB937765Q46098067-0E9A9DD9-7954-4AC2-A1AB-7FA2F1CD45C6Q46203139-68F164D8-AEE4-4364-A11A-59B6EF3A6F5BQ46660307-AF3A155C-12C8-4980-809A-4330C726BCA3Q51233705-A358927A-8416-41A5-8B75-02490C5199CE
P2860
Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Reasons for underuse of recomm ...... eterans Health Administration.
@en
Reasons for underuse of recomm ...... eterans Health Administration.
@nl
type
label
Reasons for underuse of recomm ...... eterans Health Administration.
@en
Reasons for underuse of recomm ...... eterans Health Administration.
@nl
prefLabel
Reasons for underuse of recomm ...... eterans Health Administration.
@en
Reasons for underuse of recomm ...... eterans Health Administration.
@nl
P2093
P2860
P356
P1433
P1476
Reasons for underuse of recomm ...... eterans Health Administration.
@en
P2093
Barbara J McNeil
Elizabeth B Lamont
Mary Beth Landrum
Nancy L Keating
Samuel R Bozeman
P2860
P304
P356
10.1002/CNCR.26628
P407
P577
2011-11-09T00:00:00Z